α orc1 Search Results


α orc1  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc α orc1
(A) Schematic of experiment. (B-C) Chromatin accessibility (ATAC-seq) and gene expression (RNA-seq) changes in ORC1KO. Signals significantly up-regulated (red) or down-regulated (blue) in the <t>ORC1</t> KO cells. (D-E) Same as (B-C) except for ORC5KO cells relative to WT. (F-G) Venn diagram showing overlap of ATAC changes in the three KO cells. (H) Example ORC2-dependent ATAC changes. (I-J) Venn diagram showing overlap of gene expression changes in the three KO cells.
α Orc1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/α orc1/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
α orc1 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic of experiment. (B-C) Chromatin accessibility (ATAC-seq) and gene expression (RNA-seq) changes in ORC1KO. Signals significantly up-regulated (red) or down-regulated (blue) in the ORC1 KO cells. (D-E) Same as (B-C) except for ORC5KO cells relative to WT. (F-G) Venn diagram showing overlap of ATAC changes in the three KO cells. (H) Example ORC2-dependent ATAC changes. (I-J) Venn diagram showing overlap of gene expression changes in the three KO cells.

Journal: bioRxiv

Article Title: Regulation of epigenetics and chromosome structure by human ORC2

doi: 10.1101/2024.12.18.629220

Figure Lengend Snippet: (A) Schematic of experiment. (B-C) Chromatin accessibility (ATAC-seq) and gene expression (RNA-seq) changes in ORC1KO. Signals significantly up-regulated (red) or down-regulated (blue) in the ORC1 KO cells. (D-E) Same as (B-C) except for ORC5KO cells relative to WT. (F-G) Venn diagram showing overlap of ATAC changes in the three KO cells. (H) Example ORC2-dependent ATAC changes. (I-J) Venn diagram showing overlap of gene expression changes in the three KO cells.

Article Snippet: Antibodies used include α-ORC1 (cell signaling technology, no. 4731), α-ORC2 (Santa Cruz Biotechnology, no. sc-32734), α-ORC3 (Santa Cruz Biotechnology, no. sc-23888), α-ORC4, α-ORC5, α-ORC6 (PMID15944161), α-HSP90 (Santa Cruz Biotechnology, no. sc-13119), α-MCM7 (Santa Cruz Biotechnology, no. sc-9966), α-ORCA (PMID 20932478, generous gift from Supriya G. Prasanth, University of Illinois), α-HP1α (cell signaling technology, no. 2616), α-H3K9ME1 (cell signaling technology, no. 14186), α-H3K9ME2 (cell signaling technology, no. 4658), α-H3K9ME3 (cell signaling technology, no. 13969), α-HBO1 (cell signaling technology, no. 58418), α-H3K27ME3 (cell signaling technology, no. 9733), α-Histone H3 (cell signaling technology, no. 4499), α-NFIA (Apcepta, no. AP20998c), α-CHD7 (cell signaling technology, no. 6505).

Techniques: Gene Expression, RNA Sequencing